COHERENT CORP (COHR) Fundamental Analysis & Valuation

NYSE:COHR • US19247G1076

260.64 USD
+8.32 (+3.3%)
At close: Mar 10, 2026
260.64 USD
0 (0%)
After Hours: 3/10/2026, 4:27:09 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This COHR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to COHR. COHR was compared to 124 industry peers in the Electronic Equipment, Instruments & Components industry. COHR has an average financial health and profitability rating. COHR is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

5

1. COHR Profitability Analysis

1.1 Basic Checks

  • In the past year COHR was profitable.
  • In the past year COHR had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: COHR reported negative net income in multiple years.
  • In the past 5 years COHR always reported a positive cash flow from operatings.
COHR Yearly Net Income VS EBIT VS OCF VS FCFCOHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M 600M

1.2 Ratios

  • COHR has a Return On Assets (1.27%) which is in line with its industry peers.
  • With a Return On Equity value of 2.25%, COHR perfoms like the industry average, outperforming 53.23% of the companies in the same industry.
  • COHR has a Return On Invested Capital of 4.27%. This is comparable to the rest of the industry: COHR outperforms 58.06% of its industry peers.
  • COHR had an Average Return On Invested Capital over the past 3 years of 1.91%. This is significantly below the industry average of 8.67%.
  • The 3 year average ROIC (1.91%) for COHR is below the current ROIC(4.27%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.27%
ROE 2.25%
ROIC 4.27%
ROA(3y)-1.8%
ROA(5y)0.14%
ROE(3y)-3.42%
ROE(5y)-0.03%
ROIC(3y)1.91%
ROIC(5y)3.38%
COHR Yearly ROA, ROE, ROICCOHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10

1.3 Margins

  • Looking at the Profit Margin, with a value of 3.05%, COHR is in the better half of the industry, outperforming 62.90% of the companies in the same industry.
  • COHR has a better Operating Margin (11.28%) than 77.42% of its industry peers.
  • COHR's Operating Margin has improved in the last couple of years.
  • COHR has a Gross Margin of 36.16%. This is comparable to the rest of the industry: COHR outperforms 58.06% of its industry peers.
  • COHR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 11.28%
PM (TTM) 3.05%
GM 36.16%
OM growth 3Y-9.74%
OM growth 5Y23.86%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.68%
GM growth 5Y0.42%
COHR Yearly Profit, Operating, Gross MarginsCOHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. COHR Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so COHR is destroying value.
  • Compared to 1 year ago, COHR has more shares outstanding
  • The number of shares outstanding for COHR has been increased compared to 5 years ago.
  • The debt/assets ratio for COHR has been reduced compared to a year ago.
COHR Yearly Shares OutstandingCOHR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
COHR Yearly Total Debt VS Total AssetsCOHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

2.2 Solvency

  • An Altman-Z score of 5.19 indicates that COHR is not in any danger for bankruptcy at the moment.
  • With a decent Altman-Z score value of 5.19, COHR is doing good in the industry, outperforming 74.19% of the companies in the same industry.
  • A Debt/Equity ratio of 0.38 indicates that COHR is not too dependend on debt financing.
  • COHR has a worse Debt to Equity ratio (0.38) than 65.32% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z 5.19
ROIC/WACC0.47
WACC9%
COHR Yearly LT Debt VS Equity VS FCFCOHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 2.25 indicates that COHR has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.25, COHR is in line with its industry, outperforming 45.97% of the companies in the same industry.
  • COHR has a Quick Ratio of 1.30. This is a normal value and indicates that COHR is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.30, COHR is not doing good in the industry: 63.71% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.25
Quick Ratio 1.3
COHR Yearly Current Assets VS Current LiabilitesCOHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. COHR Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 54.06% over the past year.
  • Measured over the past 5 years, COHR shows a small growth in Earnings Per Share. The EPS has been growing by 6.89% on average per year.
  • Looking at the last year, COHR shows a quite strong growth in Revenue. The Revenue has grown by 18.63% in the last year.
  • The Revenue has been growing by 19.54% on average over the past years. This is quite good.
EPS 1Y (TTM)54.06%
EPS 3Y-1.09%
EPS 5Y6.89%
EPS Q2Q%35.79%
Revenue 1Y (TTM)18.63%
Revenue growth 3Y20.55%
Revenue growth 5Y19.54%
Sales Q2Q%17.49%

3.2 Future

  • The Earnings Per Share is expected to grow by 37.73% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 20.79% on average over the next years. This is a very strong growth
EPS Next Y51.46%
EPS Next 2Y44.03%
EPS Next 3Y37.73%
EPS Next 5YN/A
Revenue Next Year19.68%
Revenue Next 2Y21.7%
Revenue Next 3Y20.79%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
COHR Yearly Revenue VS EstimatesCOHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B 10B
COHR Yearly EPS VS EstimatesCOHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

2

4. COHR Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 59.78, COHR can be considered very expensive at the moment.
  • The rest of the industry has a similar Price/Earnings ratio as COHR.
  • When comparing the Price/Earnings ratio of COHR to the average of the S&P500 Index (26.45), we can say COHR is valued expensively.
  • The Price/Forward Earnings ratio is 34.90, which means the current valuation is very expensive for COHR.
  • The rest of the industry has a similar Price/Forward Earnings ratio as COHR.
  • COHR is valuated rather expensively when we compare the Price/Forward Earnings ratio to 24.65, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 59.78
Fwd PE 34.9
COHR Price Earnings VS Forward Price EarningsCOHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as COHR.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 40.17
COHR Per share dataCOHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • COHR's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as COHR's earnings are expected to grow with 37.73% in the coming years.
PEG (NY)1.16
PEG (5Y)8.68
EPS Next 2Y44.03%
EPS Next 3Y37.73%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. COHR Dividend Analysis

5.1 Amount

  • No dividends for COHR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

COHR Fundamentals: All Metrics, Ratios and Statistics

COHERENT CORP

NYSE:COHR (3/10/2026, 4:27:09 PM)

After market: 260.64 0 (0%)

260.64

+8.32 (+3.3%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-04
Earnings (Next)05-05
Inst Owners85.4%
Inst Owner Change12.55%
Ins Owners0.51%
Ins Owner Change-3.3%
Market Cap48.86B
Revenue(TTM)6.29B
Net Income(TTM)192.22M
Analysts80.71
Price Target254.69 (-2.28%)
Short Float %2.78%
Short Ratio0.99
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.07
Dividend Growth(5Y)N/A
DP11.9%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.96%
Min EPS beat(2)4.72%
Max EPS beat(2)9.2%
EPS beat(4)4
Avg EPS beat(4)6.35%
Min EPS beat(4)4.19%
Max EPS beat(4)9.2%
EPS beat(8)8
Avg EPS beat(8)12.68%
EPS beat(12)11
Avg EPS beat(12)12.08%
EPS beat(16)15
Avg EPS beat(16)11.17%
Revenue beat(2)2
Avg Revenue beat(2)0.93%
Min Revenue beat(2)0.81%
Max Revenue beat(2)1.05%
Revenue beat(4)3
Avg Revenue beat(4)0.8%
Min Revenue beat(4)-0.56%
Max Revenue beat(4)1.9%
Revenue beat(8)7
Avg Revenue beat(8)1.07%
Revenue beat(12)8
Avg Revenue beat(12)-0.05%
Revenue beat(16)10
Avg Revenue beat(16)-0.17%
PT rev (1m)22.2%
PT rev (3m)48.43%
EPS NQ rev (1m)5.48%
EPS NQ rev (3m)5.91%
EPS NY rev (1m)4.54%
EPS NY rev (3m)5.29%
Revenue NQ rev (1m)4.2%
Revenue NQ rev (3m)4.32%
Revenue NY rev (1m)3.2%
Revenue NY rev (3m)3.61%
Valuation
Industry RankSector Rank
PE 59.78
Fwd PE 34.9
P/S 7.76
P/FCF N/A
P/OCF 123.06
P/B 5.72
P/tB 48.26
EV/EBITDA 40.17
EPS(TTM)4.36
EY1.67%
EPS(NY)7.47
Fwd EY2.87%
FCF(TTM)-0.55
FCFYN/A
OCF(TTM)2.12
OCFY0.81%
SpS33.57
BVpS45.55
TBVpS5.4
PEG (NY)1.16
PEG (5Y)8.68
Graham Number66.84
Profitability
Industry RankSector Rank
ROA 1.27%
ROE 2.25%
ROCE 5.4%
ROIC 4.27%
ROICexc 4.57%
ROICexgc 11.82%
OM 11.28%
PM (TTM) 3.05%
GM 36.16%
FCFM N/A
ROA(3y)-1.8%
ROA(5y)0.14%
ROE(3y)-3.42%
ROE(5y)-0.03%
ROIC(3y)1.91%
ROIC(5y)3.38%
ROICexc(3y)2.05%
ROICexc(5y)4.61%
ROICexgc(3y)5.86%
ROICexgc(5y)10.02%
ROCE(3y)2.42%
ROCE(5y)4.28%
ROICexgc growth 3Y-16.13%
ROICexgc growth 5Y26.18%
ROICexc growth 3Y-25.01%
ROICexc growth 5Y18.65%
OM growth 3Y-9.74%
OM growth 5Y23.86%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.68%
GM growth 5Y0.42%
F-Score7
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA 2.62
Cap/Depr 94.5%
Cap/Sales 7.96%
Interest Coverage 3.27
Cash Conversion 32.03%
Profit Quality N/A
Current Ratio 2.25
Quick Ratio 1.3
Altman-Z 5.19
F-Score7
WACC9%
ROIC/WACC0.47
Cap/Depr(3y)68.52%
Cap/Depr(5y)73.87%
Cap/Sales(3y)7.8%
Cap/Sales(5y)7.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.06%
EPS 3Y-1.09%
EPS 5Y6.89%
EPS Q2Q%35.79%
EPS Next Y51.46%
EPS Next 2Y44.03%
EPS Next 3Y37.73%
EPS Next 5YN/A
Revenue 1Y (TTM)18.63%
Revenue growth 3Y20.55%
Revenue growth 5Y19.54%
Sales Q2Q%17.49%
Revenue Next Year19.68%
Revenue Next 2Y21.7%
Revenue Next 3Y20.79%
Revenue Next 5YN/A
EBIT growth 1Y45.39%
EBIT growth 3Y8.81%
EBIT growth 5Y48.06%
EBIT Next Year60.08%
EBIT Next 3Y42.79%
EBIT Next 5YN/A
FCF growth 1Y-140.47%
FCF growth 3Y24.87%
FCF growth 5Y4.23%
OCF growth 1Y-33.8%
OCF growth 3Y15.31%
OCF growth 5Y16.34%

COHERENT CORP / COHR FAQ

What is the ChartMill fundamental rating of COHERENT CORP (COHR) stock?

ChartMill assigns a fundamental rating of 5 / 10 to COHR.


What is the valuation status of COHERENT CORP (COHR) stock?

ChartMill assigns a valuation rating of 2 / 10 to COHERENT CORP (COHR). This can be considered as Overvalued.


What is the profitability of COHR stock?

COHERENT CORP (COHR) has a profitability rating of 5 / 10.


What is the valuation of COHERENT CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for COHERENT CORP (COHR) is 59.78 and the Price/Book (PB) ratio is 5.72.


Can you provide the expected EPS growth for COHR stock?

The Earnings per Share (EPS) of COHERENT CORP (COHR) is expected to grow by 51.46% in the next year.